
Nemaura Medical NMRD
Quarterly report 2023-Q4
added 02-12-2024
Nemaura Medical Interest Expense 2011-2026 | NMRD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Nemaura Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.41 M | -6.67 M | -2.01 M | 3.93 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.93 K | -6.67 M | -3.77 M |
Quarterly Interest Expense Nemaura Medical
| 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.93 M | -825 K | -657 K | - | -1.08 M | -1.62 M | -1.45 M | - | -1.64 M | -5.14 M | -3.5 M | - | -378 K | -378 K | -542 K | -189 K | - | - | 3.93 K | - | 7.04 K | 23.9 K | 16.9 K | - | 9.99 K | 54.5 K | 9.53 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.5 K | -5.14 M | -960 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.11 | 8.21 % | $ 3.29 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.42 | -1.65 % | $ 1.41 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 12.6 | 2.61 % | $ 1.89 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 3.91 | 2.62 % | $ 828 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.38 | -0.24 % | $ 602 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 69.79 | 0.95 % | $ 103 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.96 | 1.02 % | $ 148 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 37.41 | 0.35 % | $ 1.16 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 11.03 | 2.22 % | $ 298 M | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 63.48 | 0.21 % | $ 1.88 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.42 | 0.22 % | $ 121 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 109.95 | 1.8 % | $ 191 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.81 | 3.81 % | $ 351 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 261.24 | -0.59 % | $ 7.37 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.19 | 3.79 % | $ 1.33 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.01 | -2.49 % | $ 694 M | ||
|
AxoGen
AXGN
|
167 K | $ 32.84 | 1.55 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 169.45 | 3.18 % | $ 12.7 B | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 32.76 | -2.93 % | $ 4.88 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.67 | 1.1 % | $ 151 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.11 | -1.16 % | $ 401 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 84.12 | 1.34 % | $ 2.92 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M |